Status:
COMPLETED
Non-ablative Er:YAG for Recurrent Candidiasis
Lead Sponsor:
Espacio Gaspar Clinic
Conditions:
Candidiasis, Vulvovaginal
Candidiasis of Vagina
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of the study wa to assess the safety, acceptability and effectiveness of non-ablative Er:YAG laser therapy for treatment of symptoms and microbiological conditions of women with recurren...
Detailed Description
Genital candidiasis is a common fungal infection that affects both men and women, though it is more frequently observed in women. It is estimated that up to 75% of women will experience at least one e...
Eligibility Criteria
Inclusion
- adult women (\> 18 years)
- diagnosis of recurrent vaginal yeast infection (\> 4 infection per year)
Exclusion
- patients having contraindications to laser therapy (epilepsy, pregnancy, acute systemic infection)
Key Trial Info
Start Date :
January 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2022
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT06572488
Start Date
January 3 2019
End Date
September 26 2022
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uroclinica
Mendoza, Argentina